Standard BioTools Inc. Common Stock (LAB)
PHARMACEUTICAL PREPARATIONS
Standard BioTools Inc. Common Stock (LAB) is listed on Nasdaq, where it has traded since February 10, 2011.
- Listed On
- Nasdaq
- Listed Since
- February 10, 2011
- Employees
- 389
- Market Cap
- $244M
About Standard BioTools Inc. Common Stock
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 140 institutions reported holding LAB, with 295.8 million shares worth $243.3 million in aggregate. The largest reported holder was Casdin Capital, with 88.8 million shares worth $73.0 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Casdin Capital | 88,783,856 | $73M | Unchanged |
| Viking Global Investors | 58,651,170 | $48M | Unchanged |
| Mak Capital One | 28,813,904 | $24M | Added 10.09% |
| Long Focus Capital Management | 23,500,000 | $19M | Added 46.73% |
| Vanguard | 14,946,900 | $12M | Reduced 13.39% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is LAB?
Standard BioTools Inc. Common Stock (LAB) is listed on Nasdaq, where it has traded since February 10, 2011.
Who are the largest institutional holders of LAB?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of LAB were Casdin Capital, Viking Global Investors and Mak Capital One.
How many institutions own LAB?
140 institutions reported a position in LAB for the quarter ended June 30, 2026, worth $243.3 million in total.
Did institutions buy or sell LAB last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for LAB.
Every reported institutional holder, plus insider and congressional trades in LAB, on SentiSense.